Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antitumor/Antifungal Celecoxib Derivative AR-12 is a Non-Nucleoside Inhibitor of the ANL-Family Adenylating Enzyme Acetyl CoA Synthetase
Kristy Koselny, Julianne Green, Lacey J. Favazzo, et al.
ACS Infectious Diseases (2016) Vol. 2, Iss. 4, pp. 268-280
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

The antifungal pipeline: a reality check
John R. Perfect
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 9, pp. 603-616
Open Access | Times Cited: 718
Antifungals
Sonia Campoy, José L. Adrio
Biochemical Pharmacology (2016) Vol. 133, pp. 86-96
Closed Access | Times Cited: 425
New Horizons in Antifungal Therapy
Kaila M. Pianalto, J. Andrew Alspaugh
Journal of Fungi (2016) Vol. 2, Iss. 4, pp. 26-26
Open Access | Times Cited: 181
Hope on the Horizon: Novel Fungal Treatments in Development
Adriana M. Rauseo, Ariella Coler‐Reilly, Lindsey Larson, et al.
Open Forum Infectious Diseases (2020) Vol. 7, Iss. 2
Open Access | Times Cited: 181
Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi
Matthew W. McCarthy, Dimitrios P. Kontoyiannis, Oliver A. Cornely, et al.
The Journal of Infectious Diseases (2017) Vol. 216, Iss. suppl_3, pp. S474-S483
Open Access | Times Cited: 159
HIV latency is reversed by ACSS2-driven histone crotonylation
Guochun Jiang, Don X. Nguyen, Nancie M. Archin, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 3, pp. 1190-1198
Open Access | Times Cited: 137
A comprehensive overview of the medicinal chemistry of antifungal drugs: perspectives and promise
Kaitlind C. Howard, Emily K. Dennis, David S. Watt, et al.
Chemical Society Reviews (2020) Vol. 49, Iss. 8, pp. 2426-2480
Closed Access | Times Cited: 111
The Future of Antifungal Drug Therapy: Novel Compounds and Targets
Caroline Mota Fernandes, Deveney Dasilva, Krupanandan Haranahalli, et al.
Antimicrobial Agents and Chemotherapy (2020) Vol. 65, Iss. 2
Open Access | Times Cited: 107
Prioritization of Molecular Targets for Antimalarial Drug Discovery
Barbara Forte, Sabine Ottilie, Andrew Plater, et al.
ACS Infectious Diseases (2021) Vol. 7, Iss. 10, pp. 2764-2776
Open Access | Times Cited: 71
Drug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis
Sarah E. Murphy, Tihana Bicanic
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 61
Development and research progress of anti-drug resistant fungal drugs
Xiangyi Cui, Lanlin Wang, Yuhong Lü, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 9, pp. 986-1000
Open Access | Times Cited: 47
Challenges and Opportunities for Celecoxib Repurposing
Urszula Bąk, Anna Krupa
Pharmaceutical Research (2023) Vol. 40, Iss. 10, pp. 2329-2345
Open Access | Times Cited: 28
The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis
Kristy Koselny, Julianne Green, Louis DiDone, et al.
Antimicrobial Agents and Chemotherapy (2016) Vol. 60, Iss. 12, pp. 7115-7127
Open Access | Times Cited: 78
New Approaches for Cryptococcosis Treatment
Cristina de Castro Spadari, Fernanda Wirth, Luciana B. Lopes, et al.
Microorganisms (2020) Vol. 8, Iss. 4, pp. 613-613
Open Access | Times Cited: 62
Antifungal therapeutics for dimorphic fungal pathogens
Kristie D. Goughenour, Chad A. Rappleye
Virulence (2016) Vol. 8, Iss. 2, pp. 211-221
Open Access | Times Cited: 57
Identification of triazenyl indoles as inhibitors of fungal fatty acid biosynthesis with broad-spectrum activity
Kali R. Iyer, Sheena C. Li, Nicole M. Revie, et al.
Cell chemical biology (2023) Vol. 30, Iss. 7, pp. 795-810.e8
Open Access | Times Cited: 14
New developments and directions in the clinical application of the echinocandins
Christina C. Chang, Monica A. Slavin, S. C.- A. Chen
Archives of Toxicology (2017) Vol. 91, Iss. 4, pp. 1613-1621
Closed Access | Times Cited: 48
<p>Multiresistant <em>Fusarium</em> Pathogens on Plants and Humans: Solutions in (from) the Antifungal Pipeline?</p>
Abdullah M. S. Al‐Hatmi, Sybren de Hoog, Jacques F. Meis
Infection and Drug Resistance (2019) Vol. Volume 12, pp. 3727-3737
Open Access | Times Cited: 40
Systematic analysis of the Candida albicans kinome reveals environmentally contingent protein kinase-mediated regulation of filamentation and biofilm formation in vitro and in vivo
Juraj Kramara, Min-Ju Kim, Tomye L. Ollinger, et al.
mBio (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 4
Targeting fungal lipid synthesis for antifungal drug development and potentiation of contemporary antifungals
Cecilia Gutierrez-Perez, Robert A. Cramer
npj Antimicrobials and Resistance (2025) Vol. 3, Iss. 1
Open Access
Novel AR-12 derivatives, P12-23 and P12-34, inhibit flavivirus replication by blocking host de novo pyrimidine biosynthesis
Chao‐Fu Yang, Balraj Gopula, Jian‐Jong Liang, et al.
Emerging Microbes & Infections (2018) Vol. 7, Iss. 1, pp. 1-11
Open Access | Times Cited: 32
Drugs currently under investigation for the treatment of invasive candidiasis
Matthew W. McCarthy, Thomas J. Walsh
Expert Opinion on Investigational Drugs (2017) Vol. 26, Iss. 7, pp. 825-831
Closed Access | Times Cited: 29
New and Promising Chemotherapeutics for Emerging Infections Involving Drug-resistant Non-albicans Candida Species
Laura Nunes Silva, Thaís P. Mello, Lívia S. Ramos, et al.
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 28, pp. 2527-2553
Closed Access | Times Cited: 26
Advances in Candida albicans

Infectious diseases (2021)
Open Access | Times Cited: 21
AR-12 Exhibits Direct and Host-Targeted Antibacterial Activity toward Mycobacterium abscessus
Shaoyan Zhang, Yuzhen Zou, Qi Guo, et al.
Antimicrobial Agents and Chemotherapy (2020) Vol. 64, Iss. 8
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top